Acambis Suspends Enrollment In Smallpox Vaccine Pivotal Program
By Kim Coghill
Wednesday, April 14, 2004
Government contractor Acambis plc suspended recruitment of additional volunteers in a Phase III program evaluating its smallpox vaccine candidate against Dryvax, after three out of 2,800 participants showed signs of heart inflammation. (BioWorld Today)
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.